MMJ International Holdings announced today, that it has submitted to the U.S. Food and Drug Administration (FDA) MMJ's cannabis formulation requested responses for the agency's review. The FDA had notified MMJ International Holdings of a CMC (chemistry, manufacturing, control) issue which the company completed the required complex scientific research needed to begin its clinical trials in Multiple Sclerosis and Huntington's Disease.
Cannabis researcher MMJ International Holdings Corp recently reached a milestone when it officially submitted requested responses to the U.S.
MMJ Positioned To Win DEA Lawsuit As HHS Verifies Marijuana Has Medical Benefit To Patients baltimorestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimorestar.com Daily Mail and Mail on Sunday newspapers.
MMJ International Holdings: MMJ Positioned To Win DEA Lawsuit As HHS Verifies Marijuana Has Medical Benefit To Patients finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.